BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36319794)

  • 1. Radiosurgery fractionation and post-treatment hemorrhage development for intact melanoma brain metastases.
    McKenzie G; Gaskins J; Rattani A; Oliver A; Southall W; Nakamura F; Yusuf M; Mistry A; Williams B; Woo S
    J Neurooncol; 2022 Dec; 160(3):591-599. PubMed ID: 36319794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy.
    Yusuf M; Rattani A; Gaskins J; Oliver AL; Mandish SF; Burton E; May ME; Williams B; Ding D; Sharma M; Miller D; Woo S
    J Neurooncol; 2022 Jan; 156(1):163-172. PubMed ID: 34807342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis.
    Jablonska PA; Muniz T; Ribeiro M; Liu ZA; Ye XY; Devaraja K; Laperriere N; Millar BA; Conrad T; Kongkham P; Butler M; Shultz DB
    J Neurooncol; 2023 Aug; 164(1):199-209. PubMed ID: 37552363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
    Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.
    Redmond KJ; Gui C; Benedict S; Milano MT; Grimm J; Vargo JA; Soltys SG; Yorke E; Jackson A; El Naqa I; Marks LB; Xue J; Heron DE; Kleinberg LR
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):53-67. PubMed ID: 33390244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases.
    Johannwerner L; Werner EM; Blanck O; Janssen S; Cremers F; Yu NY; Rades D
    Biology (Basel); 2023 Apr; 12(5):. PubMed ID: 37237469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
    Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of Seizures Prior to Single-fraction Radiosurgery or Multi-fraction Stereotactic Radiotherapy in Patients With Very Few Brain Metastases.
    Rades D; Witteler J; Kjaer TW; Tvilsted S; Schild SE
    Anticancer Res; 2020 Jun; 40(6):3499-3504. PubMed ID: 32487650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
    Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
    J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
    El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
    Front Oncol; 2020; 10():693. PubMed ID: 32477942
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies.
    Zoga E; Wolff R; Ackermann H; Meissner M; Rödel C; Tselis N; Chatzikonstantinou G
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy.
    Ahmed KA; Abuodeh YA; Echevarria MI; Arrington JA; Stallworth DG; Hogue C; Naghavi AO; Kim S; Kim Y; Patel BG; Sarangkasiri S; Johnstone PA; Sahebjam S; Khushalani NI; Forsyth PA; Harrison LB; Yu M; Etame AB; Caudell JJ
    Ann Oncol; 2016 Dec; 27(12):2288-2294. PubMed ID: 27637745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
    Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
    Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique.
    Ruggieri R; Naccarato S; Mazzola R; Ricchetti F; Corradini S; Fiorentino A; Alongi F
    Radiat Oncol; 2018 Mar; 13(1):38. PubMed ID: 29506539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
    Donovan EK; Parpia S; Greenspoon JN
    Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity.
    Yazici G; Kiratli H; Ozyigit G; Sari SY; Elmali A; Yilmaz MT; Koc I; Deliktas O; Gumeler E; Cengiz M; Zorlu F
    Radiother Oncol; 2022 Nov; 176():39-45. PubMed ID: 36184996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linac-based radiosurgery for multiple brain metastases: Comparison between two mono-isocenter techniques with multiple non-coplanar arcs.
    Ruggieri R; Naccarato S; Mazzola R; Ricchetti F; Corradini S; Fiorentino A; Alongi F
    Radiother Oncol; 2019 Mar; 132():70-78. PubMed ID: 30825972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.